Categories: HealthcareNews

WW International, Inc. Announces Participation in Upcoming Investor Conferences

NEW YORK, Sept. 08, 2023 (GLOBE NEWSWIRE) — WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) today announced that it will present at the following investor conferences.

Baird 2023 Global Healthcare Conference
Tuesday, September 12, 2023 at 4:55 pm ET
New York, NY
Presenters: Heather Stark, Chief Financial Officer and Gary Foster, PhD, Chief Scientific Officer

Morgan Stanley 21st Annual Global Healthcare Conference
Wednesday, September 13, 2023 at 3:35 pm ET
New York, NY
Presenters: Sima Sistani, Chief Executive Officer and Heather Stark, Chief Financial Officer

The presentations will be accessible via live audio webcast on the Company’s corporate website at corporate.ww.com in the Investors section under Presentations and Events. An archive of the webcasts will be available on this site for 30 days.

About WW International, Inc.
WeightWatchers is a human-centric technology company powered by our proven, science-based, clinically effective weight loss and weight management program. For six decades, we have inspired millions of people to adopt healthy habits for real life. We combine technology and community to help members reach and sustain their goals on our program. To learn more about the WeightWatchers approach to healthy living, please visit ww.com. For more information about our global business, visit our corporate website at corporate.ww.com.

For more information, contact:
Corey Kinger
corey.kinger@ww.com

Staff

Recent Posts

Daily Fit Notes Rolls Out Affordable Fitness Solutions for the Modern Lifestyle

Daily Fit Notes, founded by Justin Brey in New York, launches a text-based subscription fitness…

16 hours ago

WillowWood Rebrand by DD.NYC Wins Gold Anthem Award for Product and Innovation in 2024 Rebrand

MT. STERLING, Ohio, Dec. 20, 2024 /PRNewswire/ -- WillowWood, a global leader in prosthetic solutions,…

1 day ago

Quantum Biopharma Announces Closing of Second Tranche

TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"…

1 day ago

Glow Lifetech Announces Completion of Final Payment under Swiss Pharma Share Exchange Agreement and Debt Settlement

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…

1 day ago

Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Bloom Burton & Co. Inc. (Bloom Burton)…

1 day ago